Antony Loebel
Impact in
- Psychiatry and Mental health top 0.1%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Electroconvulsive Therapy Studies
- Attention Deficit Hyperactivity Disorder
- Biological Psychiatry top 1%
- Tryptophan and brain disorders
Papers in
-
- Schizophrenia research and treatment 89
- Bipolar Disorder and Treatment 81
- Attention Deficit Hyperactivity Disorder 29
- Electroconvulsive Therapy Studies 19
-
- Pharmaceutical studies and practices 17
- Co-authors
- Josephine Cucchiaro (75 shared papers)Jeffrey A. Lieberman (5 shared papers)Robert Silva (16 shared papers)David Mayerhoff (7 shared papers)Cynthia Siu (32 shared papers)Philip D. Harvey (22 shared papers)S. Szymanski (5 shared papers)Stephan Geisler (2 shared papers)
- Journals
- Schizophrenia Research (30 papers)CNS Spectrums (18 papers)European Psychiatry (16 papers)European Neuropsychopharmacology (15 papers)The Journal of Clinical Psychiatry (13 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Antony Loebel
218 papers receiving 6.3k citations
Antony Loebel's Hit Papers
Peers
Comparison fields: 5 of 106
- Psychiatry and Mental health 4.6k
- Biological Psychiatry 372
- Pharmacology 784
- Philosophy 484
- Cellular and Molecular Neuroscience 564
Countries citing papers authored by Antony Loebel
This map shows the geographic impact of Antony Loebel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antony Loebel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antony Loebel more than expected).
Fields of papers citing papers by Antony Loebel
This network shows the impact of papers produced by Antony Loebel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antony Loebel. The network helps show where Antony Loebel may publish in the future.
Co-authors
The 25 scholars most cited alongside Antony Loebel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 226 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Duration of psychosis and outcome in first-episode schizophrenia Hit paper breakdown → | 1992 | 663 |
| 2 | 2013 | 229 | |
| 3 | 1990 | 218 | |
| 4 | A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia Hit paper breakdown → | 2020 | 212 |
| 5 | 2011 | 193 | |
| 6 | 2010 | 178 | |
| 7 | 2009 | 164 | |
| 8 | 2013 | 163 | |
| 9 | 2009 | 147 | |
| 10 | 1992 | 133 | |
| 11 | 2013 | 129 | |
| 12 | 2013 | 120 | |
| 13 | 2009 | 111 | |
| 14 | 2004 | 110 | |
| 15 | 2015 | 104 | |
| 16 | 2012 | 100 | |
| 17 | 2013 | 96 | |
| 18 | 1994 | 91 | |
| 19 | 2011 | 85 | |
| 20 | 2003 | 74 |
About Antony Loebel
Antony Loebel is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health, Clinical Psychology, Pharmacology and Cognitive Neuroscience, having authored 226 papers that have together received 6.5k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (89 papers), Bipolar Disorder and Treatment (81 papers), Attention Deficit Hyperactivity Disorder (29 papers), Electroconvulsive Therapy Studies (19 papers), Pharmaceutical studies and practices (17 papers), Treatment of Major Depression (16 papers), Mental Health Research Topics (10 papers) and Functional Brain Connectivity Studies (10 papers). The work is most often cited by research in Psychiatry and Mental health (4.6k citations), Biological Psychiatry (372 citations), Pharmacology (784 citations), Philosophy (484 citations) and Cellular and Molecular Neuroscience (564 citations). Antony Loebel has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Josephine Cucchiaro, Jeffrey A. Lieberman, Robert Silva, David Mayerhoff, Cynthia Siu, Philip D. Harvey, S. Szymanski, Stephan Geisler, José Alvir and Kaushik Sarma. Their work appears in journals such as Schizophrenia Research, CNS Spectrums, European Psychiatry, European Neuropsychopharmacology and The Journal of Clinical Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.